Crestline Management’s Carter's CRI Stock Holding History

Crestline Management’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,316	Closed	-$1.86M	–	146
2024 Q4	$1.86M	Buy	34,316 +25,539	+291%	+$1.46M	0.06%	296
2024 Q3	$570K	Buy	+8,777	New	+$564K	0.03%	352

Other funds holding CRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RWWM Inc Rocklin, California $1.37B AUM 3.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Crestline Management's CRI Position: Q1 2025 in Review

Crestline Management sold out of Carter's (CRI) in Q1 2025, closing a stake of 34,316 shares — an estimated $1.86M sold.

Crestline Management first reported a position in CRI in Q3 2024 and held it in 2 quarters. The position peaked at $1.86M in Q4 2024. 286 funds tracked by Wall St. Rank hold CRI as of Q1 2025.

Crestline Management reported no remaining Carter's position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 34,316 Carter's shares in Q1 2025, an estimated $1.86M.
Crestline Management first reported a position in Carter's in Q3 2024 and held it in 2 quarters.
Crestline Management's Carter's position peaked at $1.86M in Q4 2024.
286 funds tracked by Wall St. Rank held Carter's as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.